Cellectis Акции в обращении
Что обозначает Акции в обращении в Cellectis?
Акции в обращении Cellectis является 72.094M
Какое определение для Акции в обращении?
Акции в обращении - это все акции корпорации или финансового актива, которые были разрешены, выпущены и приобретены инвесторами и находятся в их собственности.
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Акции в обращении компаний в Health Care сектор на NASDAQ по сравнению с Cellectis
Что делает Cellectis?
cellectis is a clinical-stage biopharmaceutical company focused on developing a new generation of cancer immunotherapies based on gene-edited t-cells (ucart). by capitalizing on its 18 years of expertise in gene editing – built on its flagship talen® technology and pioneering electroporation system pulseagile – cellectis uses the power of the immune system to target and eradicate cancer cells. using its life-science-focused, pioneering genome engineering technologies, cellectis’ goal is to create innovative products in multiple fields and with various target markets. cellectis is listed on the nasdaq market (ticker: clls) and on the nyse alternext market (ticker: alcls). to find out more about us, visit our website: www.cellectis.com talking about gene editing? we do it. talen® is a registered trademark owned by the cellectis group.
Компании с акции в обращении похож на Cellectis
- Shanghai MicroPort Endovascular MedTech Co имеет Акции в обращении из 71.978M
- BlackRock Municipal Income Fund Inc имеет Акции в обращении из 71.992M
- Triple имеет Акции в обращении из 71.996M
- Satin Creditcare Network имеет Акции в обращении из 72.020M
- Global Net Lease имеет Акции в обращении из 72.025M
- Stockmann Oyj Abp имеет Акции в обращении из 72.049M
- Cellectis имеет Акции в обращении из 72.094M
- Cloud DX имеет Акции в обращении из 72.094M
- Bioasis Technologies имеет Акции в обращении из 72.144M
- Urban Exposure Plc имеет Акции в обращении из 72.156M
- Titan International имеет Акции в обращении из 72.159M
- BGR Systems имеет Акции в обращении из 72.162M
- BGR Systems имеет Акции в обращении из 72.162M